Antiviral strategies for emerging infectious diseases: Cayman Chemical


The emergence and global spread of SARS-CoV-2 has prompted scientific study on an unprecedented scale, with an urgent need for vaccines and therapeutics against this novel disease.

As we endeavour to further our understanding of COVID-19 disease pathogenesis and develop protective and therapeutic strategies, Cayman Chemical (MI, USA) are continuing to deliver products and services to supply scientists worldwide with the resources necessary for advancing the field.

In this issue of Cayman Currents, explore Cayman’s available antiviral strategies against COVID-19 and other emerging infectious diseases.

View the full issue


Leave A Comment